Cdc2 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdc2 Antibodies for research in cell cycle regulation and mitosis. Cdc2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdc2, also known as cyclin-dependent kinase 1 (CDK1), plays a crucial role in the regulation of the cell cycle, particularly in the transition from G2 phase to mitosis. Its activity is tightly controlled by cyclins and various regulatory proteins, making it essential for proper cell division and proliferation. Dysregulation of Cdc2 has been implicated in various cancers, highlighting its importance as a target for therapeutic intervention. Researchers can utilize Cdc2 monoclonal antibodies to explore cell cycle checkpoints and investigate potential cancer treatments. Understanding Cdc2's role in cellular processes helps reveal new insights into disease mechanisms and potential therapeutic strategies. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge in cell cycle regulation and cancer biology.